Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exeltis USA

Exeltis USA?uq=kzBhZRuG
1972 FOUNDED
M&A STATUS
31-40 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of prescription pharmaceutical and nutraceutical products. The company's products are sold through sales representatives to the eastern United States, as well as several foreign countries. Its main products are vitamins, respiratory care, anti-infective, and pain relief treatments.

Formerly Known As
Everett Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Chemo Group
Primary Office
  • 29 Spring Street
  • West Orange, NJ 07052
  • United States

+1 (973) 000-0000

Exeltis USA Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Exeltis USA‘s full profile, request access.

Request full access to PitchBook

Exeltis USA Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000 000000 16-Dec-2013 000000000000000000 Pharmaceuticals 00000 000000
To view this company’s complete investment and acquisition history, request access »

Exeltis USA Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Exeltis USA‘s full profile, request access.

Request full access to PitchBook

Exeltis USA Executive Team (5)

Name Title Board
Seat
Contact
Info
Lucas Sigman Chief Executive Officer
Everett Felper President & Founder
James Maguire Jr. Chief Financial Officer
Terry Felper - Giordano Chief Operating Officer
John Giordano Executive Vice President